-
1
المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut des Neurosciences de Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre de Recherches Ecologiques et Evolutives sur le Cancer (MIVEGEC-CREEC), Processus Écologiques et Évolutifs au sein des Communautés (PEEC), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM), F.T. is supported by the MAVA foundation. C.A‑P. is supported by funding from the European Union Horizon 2020Research and Innovation program under the Marie Skłodowska‑Curie grant agreement No. 765492, by The National Institute of Cancer (INCa, http:// www.e‑cancer. fr), SIRIC Montpellier Cancer Grant NCa_Inserm_DGOS_12553, and the ERA‑NET TRANSCAN 2 JTC 2016 PROLIPSY, la Fondation ARC pour la Recherche sur le cancer and les Fonds de dotation AFER pour la recherche médicale.
المصدر: Genome Biology
Genome Biology, 2022, 23 (1), pp.214. ⟨10.1186/s13059-022-02791-y⟩مصطلحات موضوعية: [SDV.GEN]Life Sciences [q-bio]/Genetics, MESH: Humans, [SDV.BIO]Life Sciences [q-bio]/Biotechnology, MESH: Sleep, Circulating tumor cells, Circadian cycle, MESH: Neoplastic Cells, Circulating, Neoplastic Cells, Circulating, Circadian Rhythm, Metastasis, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Humans, MESH: Circadian Rhythm, Sleep
-
2
المؤلفون: Jaafar Bennouna, Christophe Borg, Cécile Badoual, Jean-Baptiste Bachet, Julien Taieb, François Ghiringhelli, Florence Castan, Elie Marcheteau, Sophie Gourgou, Aurélie Cazes, Christelle De La Fouchardiere, Simon Pernot, Olivier Bouché, Trevor Stanbury, Eric Francois, Emmanuelle Samalin, Magali Terme, David Malka, Michel Ducreux
المساهمون: Unité Fonctionnelle de Pharmacogénétique et Oncologie Moléculaire [AP-HP Hôpital Européen Georges Pompidou] (Service de Biochimie), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Paris-Centre de Recherche Cardiovasculaire (PARCC - UMR-S U970), Université Paris Descartes - Paris 5 (UPD5)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d’anatomo‑pathologie [AP-HP Hôpital Européen Georges Pompidou] (Centre de Ressources biologiques), Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Reims (CHU Reims), Institut de Cancérologie de l'Ouest, Centre Antoine Lacassagne, CRLCC Antoine Lacassagne, Centre Régional de Lutte contre le cancer - Centre Georges-François Leclerc (CRLCC - CGFL), Centre Léon Bérard [Lyon], CRLC Val d'Aurelle-Paul Lamarque, CRLCC Val d'Aurelle - Paul Lamarque, CHU Pitié-Salpêtrière [APHP], Service d'Oncologie Médicale [CHRU Besançon], Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Université de Franche-Comté (UFC), Institut Gustave Roussy (IGR), Oncologie digestive, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), UNICANCER - Institut régional du Cancer [Montpellier] (ICM), Unité Fonctionnelle de Pharmacogénétique et Oncologie Moléculaire [AP-HP Hôpital Européen Georges Pompidou] ( Service de Biochimie ), Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Paris-Centre de Recherche Cardiovasculaire ( PARCC - U970 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Service d’anatomo‑pathologie [AP-HP Hôpital Européen Georges Pompidou] ( Centre de Ressources biologiques ), Hôpital Européen Georges Pompidou [APHP] ( HEGP ), Institut de Recherche en Cancérologie de Montpellier ( IRCM - U1194 Inserm - UM ), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Centre Hospitalier Universitaire de Reims ( CHU Reims ), Centre Régional de Lutte contre le cancer - Centre Georges-François Leclerc ( CRLCC - CGFL ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université de Franche-Comté ( UFC ), Institut Gustave Roussy ( IGR ), Institut Gustave Roussy ( IGR ) -Institut Gustave Roussy ( IGR ), UNICANCER - Institut régional du Cancer [Montpellier] ( ICM ), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle (ICM)
المصدر: European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 79 (8), pp.15-22. ⟨10.1016/j.ejca.2017.03.036⟩
www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub
European journal of cancer (Oxford, England : 1990)
European journal of cancer (Oxford, England : 1990), 2017, 79 (8), pp.15-22. 〈www.sciencedirect.com/science/article/pii/S0959804917308742?via%3Dihub〉. 〈10.1016/j.ejca.2017.03.036〉مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, Esophageal Neoplasms, Organoplatinum Compounds, MESH : Antineoplastic Combined Chemotherapy Protocols, Leucovorin, Cell Count, MESH : Leucovorin, Kaplan-Meier Estimate, MESH : Cell Count, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 0302 clinical medicine, Prostate, Circulating tumour cells, Antineoplastic Combined Chemotherapy Protocols, MESH : Stomach Neoplasms, MESH : Esophagogastric Junction, MESH : Female, MESH: Treatment Outcome, MESH : Prognosis, MESH: Organoplatinum Compounds, MESH: Stomach Neoplasms, Neoplastic Cells, Circulating, Prognosis, 3. Good health, Oxaliplatin, Clinical trial, MESH: Antineoplastic Combined Chemotherapy Protocols, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, MESH: Esophageal Neoplasms, Monoclonal, Disease Progression, MESH : Fluorouracil, MESH : Disease-Free Survival, Adenocarcinoma, Female, MESH: Disease Progression, Esophagogastric Junction, Fluorouracil, MESH: Esophagogastric Junction, medicine.drug, medicine.medical_specialty, MESH : Male, Stomach neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH : Treatment Outcome, MESH: Neoplastic Cells, Circulating, Antibodies, Monoclonal, Humanized, MESH : Organoplatinum Compounds, Disease-Free Survival, MESH : Antibodies, Monoclonal, Humanized, MESH: Prognosis, MESH : Kaplan-Meier Estimate, 03 medical and health sciences, Internal medicine, medicine, Humans, In patient, Clinical significance, MESH: Kaplan-Meier Estimate, MESH: Humans, MESH: Cell Count, business.industry, MESH : Humans, Therapeutic effect, MESH : Disease Progression, medicine.disease, MESH: Male, 030104 developmental biology, MESH: Antibodies, Monoclonal, Humanized, MESH : Neoplastic Cells, Circulating, MESH: Disease-Free Survival, MESH : Esophageal Neoplasms, MESH: Leucovorin, business, MESH: Female, MESH: Fluorouracil, Biomarkers
-
3
المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM)
المصدر: Cells
Cells, MDPI, 2020, 9 (8), pp.1836. ⟨10.3390/cells9081836⟩
Cells, Vol 9, Iss 1836, p 1836 (2020)مصطلحات موضوعية: 0301 basic medicine, epithelial cancer, Epithelial-Mesenchymal Transition, Epithelial cancer, Review, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, circulating tumor cells, MESH: Neoplastic Cells, Circulating, MESH: Prognosis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Circulating tumor cell, Neoplasms, MESH: Molecular Targeted Therapy, Biomarkers, Tumor, Humans, MESH: Neoplasms, Epithelial–mesenchymal transition, Molecular Targeted Therapy, Neoplasm Metastasis, lcsh:QH301-705.5, Metastatic cascade, MESH: Humans, Transition (genetics), Chemistry, Epithelial cell adhesion molecule, General Medicine, MESH: Gene Expression Regulation, Neoplastic, epithelial-tomesenchymal transition, Neoplastic Cells, Circulating, Prognosis, MESH: Neoplasm Metastasis, Gene Expression Regulation, Neoplastic, 030104 developmental biology, MESH: Epithelial-Mesenchymal Transition, lcsh:Biology (General), 030220 oncology & carcinogenesis, Cancer research, epithelial-to-mesenchymal transition, MESH: Biomarkers, Tumor, epithelial cell adhesion molecule, MESH: Epithelial Cell Adhesion Molecule
-
4
المؤلفون: D. Cupissol, Renaud Garrel, C. Alix-Panabieres
المساهمون: Hôpital Gui de Chauliac, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut du Cancer de Montpellier (ICM), Laboratoire Cellules Circulantes Rares Humaines [CHRU Montpellier] (LCCRH), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi
المصدر: European Annals of Otorhinolaryngology, Head and Neck Diseases
European Annals of Otorhinolaryngology, Head and Neck Diseases, Elsevier Masson, 2020, 137 (3), pp.235. ⟨10.1016/j.anorl.2019.12.012⟩مصطلحات موضوعية: Oncology, 030213 general clinical medicine, medicine.medical_specialty, MESH: Humans, business.industry, MESH: Cell Count, Head and neck cancer, MEDLINE, MESH: Carcinoma, Squamous Cell, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Neoplastic Cells, Circulating, medicine.disease, 3. Good health, MESH: Head and Neck Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Otorhinolaryngology, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Surgery, business
-
5
المؤلفون: Marie-Therese Haider, Laure Cayrefourcq, Nico Hinz, Klaus Pantel, Catherine Alix-Panabières, Daniel J Smit, Manfred Jücker
المساهمون: Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Laboratoire Cellules Circulantes Rares Humaines [CHRU Montpellier] (LCCRH), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-CHU Saint-Eloi
المصدر: Cells
Cells, MDPI, 2020, 9 (9), pp.2129. ⟨10.3390/cells9092129⟩
Volume 9
Issue 9
Cells, Vol 9, Iss 2129, p 2129 (2020)مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, MESH: Signal Transduction, AKT1, Apoptosis, AKT2, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Circulating tumor cell, MESH: Protein Kinase Inhibitors, MK2206, Phosphorylation, lcsh:QH301-705.5, MESH: Inhibitory Concentration 50, Chemistry, TOR Serine-Threonine Kinases, drug sensitivity assays, General Medicine, personalized medicine, MESH: Gene Expression Regulation, Neoplastic, Neoplastic Cells, Circulating, targeted therapy, 3. Good health, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, MESH: HEK293 Cells, PI3K/AKT/mTOR pathway, Signal transduction, CTCs, Colorectal Neoplasms, Heterocyclic Compounds, 3-Ring, Signal Transduction, MESH: Cell Line, Tumor, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, circulating tumor cells, MESH: Everolimus, MESH: Neoplastic Cells, Circulating, Article, MESH: Cell Adhesion, Inhibitory Concentration 50, 03 medical and health sciences, colorectal carcinoma, Cell Line, Tumor, MESH: Cell Proliferation, Cell Adhesion, Humans, Everolimus, Protein Kinase Inhibitors, Protein kinase B, RAD001, MESH: TOR Serine-Threonine Kinases, Cell Proliferation, MESH: Heterocyclic Compounds, 3-Ring, MESH: Humans, MESH: Phosphorylation, Cell growth, MESH: Proto-Oncogene Proteins c-akt, AKT, dual targeting, MESH: Apoptosis, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, HEK293 Cells, 030104 developmental biology, lcsh:Biology (General), MESH: Phosphatidylinositol 3-Kinases, Cancer research, MESH: Antineoplastic Agents, Proto-Oncogene Proteins c-akt, MESH: Colorectal Neoplasms
وصف الملف: application/pdf
-
6
المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE)
المصدر: Clinical Chemistry
Clinical Chemistry, American Association for Clinical Chemistry, 2020, 66 (1), pp.97-104. ⟨10.1373/clinchem.2019.303586⟩مصطلحات موضوعية: 0301 basic medicine, Proto-Oncogene Proteins B-raf, Proteome, MESH: Proto-Oncogene Proteins B-raf / genetics, Receptor, ErbB-2 / genetics, Receptor, ErbB-2 / metabolism, Transcriptome, ras Proteins / genetics, Receptor, ErbB-2, Clinical Biochemistry, Programmed Cell Death 1 Receptor, MESH: Biomarkers, Tumor / genetics, Biomarkers, Tumor / metabolism, Humans, Liquid Biopsy, Neoplastic Cells, Circulating / metabolism, [SDV.CAN]Life Sciences [q-bio]/Cancer, Computational biology, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Clinical information, medicine, Biomarkers, Tumor, Functional studies, Liquid biopsy, business.industry, Biochemistry (medical), Cancer, medicine.disease, Neoplastic Cells, Circulating, 3. Good health, MESH: Neoplastic Cells, Circulating / pathology, Programmed Cell Death 1 Receptor / genetics, Programmed Cell Death 1 Receptor / metabolism, Proteome / metabolism, 030104 developmental biology, 030220 oncology & carcinogenesis, Tissue biopsies, ras Proteins, business
-
7
المؤلفون: Alain R. Thierry, Rita Tanos
المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
المصدر: médecine/sciences
médecine/sciences, EDP Sciences, 2018, 34 (10), pp.824-832. ⟨10.1051/medsci/2018208⟩مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Neoplastic Cells, Circulating, General Biochemistry, Genetics and Molecular Biology, MESH: Prognosis, 03 medical and health sciences, 0302 clinical medicine, Circulating tumor cell, Cancer Screening Tests, Cancer screening, medicine, MESH: Early Detection of Cancer, MESH: Neoplasms, Liquid biopsy, Intensive care medicine, ComputingMilieux_MISCELLANEOUS, MESH: Humans, business.industry, Cancer, General Medicine, medicine.disease, 3. Good health, Circulating MicroRNA, Circulating biomarkers, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer biomarkers, MESH: Biomarkers, Tumor, business, MESH: Liquid Biopsy, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb0b6b8b81148ea632577c0823fcb82
https://hal.umontpellier.fr/hal-02292799/document -
8
المؤلفون: Alain R, Thierry, Rita, Tanos
المساهمون: Herrada, Anthony, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
المصدر: médecine/sciences
médecine/sciences, EDP Sciences, 2018, 34 (10), pp.824-832. ⟨10.1051/medsci/2018208⟩مصطلحات موضوعية: [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Humans, Liquid Biopsy, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Neoplastic Cells, Circulating, Neoplastic Cells, Circulating, Prognosis, MESH: Prognosis, [SDV.CAN] Life Sciences [q-bio]/Cancer, Neoplasms, Biomarkers, Tumor, Humans, MESH: Early Detection of Cancer, MESH: Neoplasms, MESH: Biomarkers, Tumor, MESH: Liquid Biopsy, Early Detection of Cancer, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6d7770f91a9281574727ac3bc16dd74f
https://hal.umontpellier.fr/hal-02292799/document -
9
المؤلفون: Kerjouan, Mallorie, Jouneau, Stéphane, Corre, Romain, Le Ho, H., Pracht, M., Léna, H., Desrues, Benoit
المساهمون: Service de pneumologie [Rennes] = Pneumology [Rennes], CHU Pontchaillou [Rennes], Département d'oncologie médicale [Rennes], CRLCC Eugène Marquis (CRLCC)
المصدر: Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, Elsevier Masson, 2013, 30 (2), pp.125-36. ⟨10.1016/j.rmr.2012.11.003⟩مصطلحات موضوعية: MESH: Contraception, MESH: Abnormalities, Drug-Induced, MESH: Smoking, MESH: Radiotherapy, MESH: Maternal-Fetal Exchange, MESH: Neoplastic Cells, Circulating, MESH: Disease Management, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, MESH: Prognosis, MESH: Pregnancy, MESH: Risk Factors, Toxicité fœtale, MESH: Neoplasms, MESH: Incidence, MESH: Humans, MESH: Abortion, Therapeutic, MESH: Diagnostic Imaging, MESH: Infant, Newborn, MESH: Fetus, MESH: Adult, MESH: Abnormalities, Radiation-Induced, MESH: Pregnancy Outcome, Cancer bronchopulmonaire, MESH: Lung Neoplasms, Grossesse, Imagerie, MESH: Breast Feeding, MESH: Pregnancy Complications, Neoplastic, MESH: Antineoplastic Agents, MESH: Maternal Age, MESH: Female, Chimiothérapie
-
10
المؤلفون: Bidard, François-Clément, Saliba, Antoine-Emmanuel, Saias, Laure, Degeorges, Armelle, De Cremoux, Patricia, Viovy, Jean-Louis, Vincent-Salomon, Anne, Mathiot, Claire, Pierga, Jean-Yves, De Gramont, Aimery
المساهمون: Service d'Oncologie Médicale, Institut Curie [Paris], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Association d'Enseignement et de Recherche des Internes en Oncologie (AERIO), AERIO, Physico-Chimie-Curie (PCC), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Curie [Paris]-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Unité de pharmacologie, Département de Pathologie, Laboratoire d'Hématologie biologique, Centre National de la Recherche Scientifique (CNRS)-Institut Curie [Paris]-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Chimie du CNRS (INC)
المصدر: Bulletin du Cancer
Bulletin du Cancer, 2009, 96 (1), pp.73-86. ⟨10.1684/bdc.2008.0797⟩
Bulletin du Cancer, John Libbey Eurotext, 2009, 96 (1), pp.73-86. ⟨10.1684/bdc.2008.0797⟩مصطلحات موضوعية: CellSearch, MESH: Humans, Microfluidique, education, Circulating tumor cells, Cellules tumorales circulantes, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Neoplastic Cells, Circulating, MESH: Cell Separation, MESH: Leukocytes, Mononuclear, Breast cancer, Microfluidic, MESH: Filtration, MESH: Reverse Transcriptase Polymerase Chain Reaction, ISET, Adnagen, MESH: Microfluidic Analytical Techniques, MESH: Female, Cancer du sein, MESH: Breast Neoplasms, MESH: RNA, Messenger
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::445a15a6fb342e8a7daee55baede771f
https://www.hal.inserm.fr/inserm-00392386/file/BulletinK_art.pdf
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey